X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with Merck Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs MERCK LTD - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

MERCK LTD 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER MERCK LTD PFIZER/
MERCK LTD
 
P/E (TTM) x 31.4 33.3 94.2% View Chart
P/BV x 5.0 3.7 133.8% View Chart
Dividend Yield % 0.6 0.8 85.6%  

Financials

 PFIZER   MERCK LTD
EQUITY SHARE DATA
    PFIZER
Mar-16
MERCK LTD
Dec-16
PFIZER/
MERCK LTD
5-Yr Chart
Click to enlarge
High Rs2,7241,060 257.0%   
Low Rs1,611623 258.6%   
Sales per share (Unadj.) Rs440.9632.4 69.7%  
Earnings per share (Unadj.) Rs48.745.7 106.5%  
Cash flow per share (Unadj.) Rs75.862.3 121.6%  
Dividends per share (Unadj.) Rs15.0011.00 136.4%  
Dividend yield (eoy) %0.71.3 52.9%  
Book value per share (Unadj.) Rs462.9388.8 119.1%  
Shares outstanding (eoy) m45.7516.60 275.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.91.3 369.5%   
Avg P/E ratio x44.518.4 241.8%  
P/CF ratio (eoy) x28.613.5 211.8%  
Price / Book Value ratio x4.72.2 216.3%  
Dividend payout %30.824.1 128.0%   
Avg Mkt Cap Rs m99,16313,969 709.9%   
No. of employees `0002.91.6 182.5%   
Total wages/salary Rs m2,7581,487 185.5%   
Avg. sales/employee Rs Th6,981.76,631.9 105.3%   
Avg. wages/employee Rs Th954.5939.2 101.6%   
Avg. net profit/employee Rs Th771.1479.4 160.8%   
INCOME DATA
Net Sales Rs m20,17010,498 192.1%  
Other income Rs m857242 353.7%   
Total revenues Rs m21,02810,741 195.8%   
Gross profit Rs m4,3101,135 379.6%  
Depreciation Rs m1,239276 449.6%   
Interest Rs m50-   
Profit before tax Rs m3,9231,102 356.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m990-   
Tax Rs m1,794343 522.7%   
Profit after tax Rs m2,228759 293.6%  
Gross profit margin %21.410.8 197.6%  
Effective tax rate %45.731.1 146.8%   
Net profit margin %11.07.2 152.8%  
BALANCE SHEET DATA
Current assets Rs m16,2996,410 254.3%   
Current liabilities Rs m7,5948,828 86.0%   
Net working cap to sales %43.2-23.0 -187.3%  
Current ratio x2.10.7 295.6%  
Inventory Days Days6558 113.2%  
Debtors Days Days2638 67.1%  
Net fixed assets Rs m8,6221,406 613.0%   
Share capital Rs m458166 275.6%   
"Free" reserves Rs m20,7226,286 329.7%   
Net worth Rs m21,1806,455 328.1%   
Long term debt Rs m250-   
Total assets Rs m29,1378,828 330.0%  
Interest coverage x755.5NM-  
Debt to equity ratio x00-  
Sales to assets ratio x0.71.2 58.2%   
Return on assets %7.78.6 89.2%  
Return on equity %10.511.8 89.5%  
Return on capital %19.017.1 111.2%  
Exports to sales %0.18.3 0.7%   
Imports to sales %17.521.0 83.1%   
Exports (fob) Rs m12869 1.4%   
Imports (cif) Rs m3,5262,209 159.6%   
Fx inflow Rs m52959 5.4%   
Fx outflow Rs m1402,612 5.4%   
Net fx Rs m-88-1,653 5.3%   
CASH FLOW
From Operations Rs m3,4361,070 321.0%  
From Investments Rs m-6,991-750 932.5%  
From Financial Activity Rs m-619-150 413.1%  
Net Cashflow Rs m-4,174171 -2,442.1%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 63.9 51.8 123.4%  
Indian inst/Mut Fund % 7.5 18.2 41.2%  
FIIs % 4.9 1.0 490.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 29.1 81.4%  
Shareholders   85,207 28,591 298.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   PANACEA BIOTECH  DISHMAN PHARMA  TTK HEALTHCARE  NATCO PHARMA  DIVIS LABORATORIES  

Compare PFIZER With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Strong US Markets; SBI, Tata Steel & Other Top Cues to Sway the Markets Today(Pre-Open)

After opening the day in green, share markets in India witnessed negative trading activity throughout the day and ended the day on a weak note.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

What Should Mutual Fund Investors Do After LTCG Tax Norms(Outside View)

Feb 6, 2018

PersonalFN explain what investors should after LTCG tax norms.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Feb 16, 2018 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS